Incannex Healthcare Limited ( IXHL) - Key Metrics
IXHL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.56 | -$0.78 | -$0.79 |
| 2025Q4 | $0.01 | -$3.44 | -$0.11 | -$0.10 |
| 2025Q3 | ? | -$0.34 | ? | ? |
| 2025Q2 | $0.02 | -$1.36 | -$0.54 | -$0.54 |
| 2025Q1 | $0.01 | -$0.45 | ? | ? |
IXHL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.48 |
| 2025Q4 | 0% | -2.34 |
| 2025Q3 | ? | -0.50 |
| 2025Q2 | 0% | -18.28 |
| 2025Q1 | ? | -1.10 |
IXHL
Price: $3.80
52 week price:
Earnings Per Share: -16.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 41.3 million